-
Story /Ice hockey used to help Tyler Patron combat cystic fibrosis, but he hopes the lab could yield stronger medicine.
-
Story /A Novartis team blazes new trails with an experimental treatment for spinal muscular atrophy.
-
Story /Ambitious scientist accelerates research into African genomic diversity and health challenges with internship
-
Story /Blocking an inflammatory pathway may offer a new way to treat autoimmune disease.
-
Story /Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.
-
Story /The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.
-
Featured News /
Cell Therapies Pty Ltd has become the first approved CAR-T commercial manufacturing site in Australia, providing potentially faster access to CAR-T therapies to eligible patients in the region with life-threatening blood cancers.
Novartis global commercial CAR-T manufacturing footprint now spans four continents, bringing these transformative therapies closer to patients and healthcare professionals around the world. -
Story / -
Story /Experts call for significant changes to facilitate the discovery of new treatments.
-
Featured News /
Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond, a first in the healthcare industry.
Pagination
- ‹ Previous page
- 1
- …
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- …
- 280
- › Next page